Zetes Industries (EBR:ZTS)

Forbes  Oct 24  Comment 
Investors in Zoetis Inc (NYSE: ZTS) saw new options become available today, for the December 16th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ZTS options chain for the new December 16th contracts and...
Motley Fool  Sep 22  Comment 
Zoetis' market share-leading status makes it an important stock for investors to consider owning in portfolios.
Forbes  Sep 7  Comment 
The directors of a company tend to have a unique inside view into the business, so when directors make major buys, investors are wise to take notice. Presumably the only reason a director of a company would choose to take their hard-earned cash...
Motley Fool  Sep 1  Comment 
As owners spend increasingly more on pets, this company stands to profit.
Forbes  Aug 4  Comment 
Among the underlying components of the S&P 500 index, we saw noteworthy options trading volume today in Walt Disney Co. (NYSE: DIS), where a total of 32,910 contracts have traded so far, representing approximately 3.3 million underlying shares....
Benzinga  Jun 10  Comment 
Zoetis Inc (NYSE: ZTS) has been meaningfully outperforming specialty pharma peers year-to-date. Citi’s Liav Abraham downgraded the company from Buy to Neutral, while raising the price target from $46 to $50. Upside Unlikely While...
Benzinga  Jun 1  Comment 
Stifel's Jonathan Block initiated coverage on Zoetis Inc (Nyse: ZTS) with a Buy rating and a price target of $58.00. Block estimated that "worldwide peak sales could reach $400 to $500 million versus management's estimate of > $300 million."...
Benzinga  Apr 25  Comment 
Activist investor Pershing Square disclosed in a regulatory filing on Friday afternoon its ownership stake in Zoetis Inc (NYSE: ZTS) remains unchanged at 8.4 percent. In the regulatory filing, Bill Ackman's fund said it is "pleased" with...



Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki